Biphenyl Compounds
"Biphenyl Compounds" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
No definition found.
Descriptor ID |
D001713
|
MeSH Number(s) |
D02.455.426.559.389.185
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Biphenyl Compounds".
Below are MeSH descriptors whose meaning is more specific than "Biphenyl Compounds".
This graph shows the total number of publications written about "Biphenyl Compounds" by people in UAMS Profiles by year, and whether "Biphenyl Compounds" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2024 | 0 | 1 | 1 | 2021 | 0 | 3 | 3 | 2018 | 0 | 2 | 2 | 2017 | 0 | 1 | 1 | 2016 | 0 | 1 | 1 | 2015 | 0 | 2 | 2 | 2014 | 0 | 2 | 2 | 2013 | 1 | 0 | 1 | 2012 | 0 | 1 | 1 | 2009 | 1 | 0 | 1 | 2008 | 1 | 0 | 1 | 2007 | 0 | 1 | 1 | 2005 | 0 | 2 | 2 | 2004 | 0 | 3 | 3 | 2002 | 0 | 1 | 1 | 1994 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Biphenyl Compounds" by people in Profiles over the past ten years.
-
Song J, Bao R, Lin M, Li W, Zhao P, Liu X, Fu Q. Investigation of the dissolution rate and oral bioavailability of atenolol-irbesartan co-amorphous systems. Int J Pharm. 2024 Nov 15; 665:124704.
-
Cao X, Khare S, DeLoid GM, Gokulan K, Demokritou P. Co-exposure to boscalid and TiO2 (E171) or SiO2 (E551) downregulates cell junction gene expression in small intestinal epithelium cellular model and increases pesticide translocation. NanoImpact. 2021 04; 22.
-
Cao X, Khare S, DeLoid GM, Gokulan K, Demokritou P. Co-exposure to boscalid and TiO2 (E171) or SiO2 (E551) downregulates cell junction gene expression in small intestinal epithelium cellular model and increases pesticide translocation. NanoImpact. 2021 04; 22:100306.
-
Salah HM, Fudim M, Al'Aref SJ, Khan MS, Almarzooq ZI, Devabhaktuni SR, Mentz RJ, Butler J, Greene SJ. Meta-Analysis of Efficacy of Sacubitril/Valsartan in Heart Failure With Preserved Ejection Fraction. Am J Cardiol. 2021 04 15; 145:165-168.
-
Ahmed HA, Ishrat T, Pillai B, Fouda AY, Sayed MA, Eldahshan W, Waller JL, Ergul A, Fagan SC. RAS modulation prevents progressive cognitive impairment after experimental stroke: a randomized, blinded preclinical trial. J Neuroinflammation. 2018 Aug 13; 15(1):229.
-
Yandrapalli S, Khan MH, Rochlani Y, Aronow WS. Sacubitril/valsartan in cardiovascular disease: evidence to date and place in therapy. Ther Adv Cardiovasc Dis. 2018 Aug; 12(8):217-231.
-
Hejazi II, Khanam R, Mehdi SH, Bhat AR, Moshahid Alam Rizvi M, Islam A, Thakur SC, Athar F. New insights into the antioxidant and apoptotic potential of Glycyrrhiza glabra L. during hydrogen peroxide mediated oxidative stress: An in vitro and in silico evaluation. Biomed Pharmacother. 2017 Oct; 94:265-279.
-
Fouda AY, Alhusban A, Ishrat T, Pillai B, Eldahshan W, Waller JL, Ergul A, Fagan SC. Brain-Derived Neurotrophic Factor Knockdown Blocks the Angiogenic and Protective Effects of Angiotensin Modulation After Experimental Stroke. Mol Neurobiol. 2017 01; 54(1):661-670.
-
Soliman S, Ishrat T, Fouda AY, Patel A, Pillai B, Fagan SC. Sequential Therapy with Minocycline and Candesartan Improves Long-Term Recovery After Experimental Stroke. Transl Stroke Res. 2015 Aug; 6(4):309-22.
-
Barreto-Torres G, Hernandez JS, Jang S, Rodr?guez-Mu?oz AR, Torres-Ramos CA, Basnakian AG, Javadov S. The beneficial effects of AMP kinase activation against oxidative stress are associated with prevention of PPARa-cyclophilin D interaction in cardiomyocytes. Am J Physiol Heart Circ Physiol. 2015 Apr 01; 308(7):H749-58.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|